The R21 malaria vaccine: Spotlight on policy goals and pathways to African vaccine manufacturing.

Competing Interests: The authors declare no conflict of interest related to this Opinion paper. OA has served as a paid consultant to the World Health Organization, including its Global Malaria Program, and was founding director of the Affordable Medicines Facility for Malaria. PY is a globally recognized expert in supply chain management. RP has served as Director of the United States President’s Malaria Initiative. WM is Executive Director of the Multilateral Initiative on Malaria.